![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of SLC7A6 mRNA | CTD | PMID:25075043 | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | increases expression | ISO | RGD:1553153 | 6480464 | 2 more ... | CTD | PMID:25575267 | 1,2-dichloroethane | decreases expression | ISO | RGD:1553153 | 6480464 | ethylene dichloride results in decreased expression of SLC7A6 mRNA | CTD | PMID:28960355 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1553153 | 6480464 | Ethinyl Estradiol affects the expression of SLC7A6 mRNA | CTD | PMID:17555576 | 17beta-estradiol | increases expression | ISO | RGD:1553153 | 6480464 | Estradiol results in increased expression of SLC7A6 mRNA | CTD | PMID:25575267 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC7A6 mRNA | CTD | PMID:31614463 | 2,3',4,4',5-Pentachlorobiphenyl | decreases expression | ISO | RGD:1553153 | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1553153 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC7A6 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1309193 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC7A6 mRNA | CTD | PMID:33387578 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC7A6 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC7A6 mRNA | CTD | PMID:28628672 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1553153 | 6480464 | Fenretinide results in decreased expression of SLC7A6 mRNA | CTD | PMID:28973697 | acetamide | increases expression | ISO | RGD:1309193 | 6480464 | acetamide results in increased expression of SLC7A6 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | ISO | RGD:1309193 | 6480464 | Acrylamide results in increased expression of SLC7A6 mRNA | CTD | PMID:28959563 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of SLC7A6 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of SLC7A6 mRNA | CTD | PMID:21641981 more ... | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of SLC7A6 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SLC7A6 mRNA | CTD | PMID:33167477 | alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of SLC7A6 mRNA | CTD | PMID:25075043 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of SLC7A6 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | RGD:1553153 | 6480464 | Benzo(a)pyrene results in decreased expression of SLC7A6 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of SLC7A6 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of SLC7A6 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1553153 | 6480464 | Benzo(a)pyrene results in increased expression of SLC7A6 mRNA | CTD | PMID:22228805 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | benzo[a]pyrene diol epoxide I | increases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:26238291 | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of SLC7A6 intron | CTD | PMID:30157460 | bisphenol A | increases expression | ISO | RGD:1553153 | 6480464 | bisphenol A results in increased expression of SLC7A6 mRNA | CTD | PMID:25575267 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC7A6 gene | CTD | PMID:31601247 | bisphenol A | affects methylation | EXP | | 6480464 | bisphenol A affects the methylation of SLC7A6 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC7A6 mRNA | CTD | PMID:29275510 | bisphenol A | increases expression | ISO | RGD:1309193 | 6480464 | bisphenol A results in increased expression of SLC7A6 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1553153 | 6480464 | bisphenol A results in decreased expression of SLC7A6 mRNA | CTD | PMID:26063408 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of SLC7A6 mRNA | CTD | PMID:26079696 | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of SLC7A6 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | RGD:1553153 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | ISO | RGD:1553153 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC7A6 mRNA | CTD | PMID:20938992 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of SLC7A6 mRNA | CTD | PMID:19320972 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of SLC7A6 mRNA | CTD | PMID:19376846 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of SLC7A6 mRNA | CTD | PMID:19549813 | crocidolite asbestos | decreases expression | ISO | RGD:1553153 | 6480464 | Asbestos, Crocidolite results in decreased expression of SLC7A6 mRNA | CTD | PMID:29279043 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SLC7A6 mRNA | CTD | PMID:20106945 | cylindrospermopsin | increases expression | EXP | | 6480464 | cylindrospermopsin results in increased expression of SLC7A6 mRNA | CTD | PMID:24921660 | dexamethasone | multiple interactions | ISO | RGD:1309193 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of SLC7A6 mRNA] | CTD | PMID:20032058 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC7A6 mRNA | CTD | PMID:28628672 | dexamethasone | multiple interactions | ISO | RGD:1553153 | 6480464 | [Dexamethasone co-treated with INS protein co-treated with PRL protein] results in decreased expression of SLC7A6 mRNA | CTD | PMID:28174119 | dexamethasone | increases expression | ISO | RGD:1309193 | 6480464 | Dexamethasone results in increased expression of SLC7A6 mRNA | CTD | PMID:20032058 | dextran sulfate | multiple interactions | ISO | RGD:1553153 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC7A6 mRNA | CTD | PMID:29950665 | dibutyl phthalate | increases expression | ISO | RGD:1553153 | 6480464 | Dibutyl Phthalate results in increased expression of SLC7A6 mRNA | CTD | PMID:21266533 | diethylstilbestrol | increases expression | ISO | RGD:1553153 | 6480464 | Diethylstilbestrol results in increased expression of SLC7A6 mRNA | CTD | PMID:25575267 | dioxygen | multiple interactions | ISO | RGD:1553153 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC7A6 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of SLC7A6 mRNA | CTD | PMID:29803840 | estriol | increases expression | ISO | RGD:1553153 | 6480464 | Estriol results in increased expression of SLC7A6 mRNA | CTD | PMID:25575267 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of SLC7A6 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | RGD:1553153 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC7A6 mRNA | CTD | PMID:20938992 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of SLC7A6 mRNA | CTD | PMID:23649840 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC7A6 gene | CTD | PMID:31601247 | heptachlor | decreases expression | ISO | RGD:1309193 | 6480464 | Heptachlor results in decreased expression of SLC7A6 mRNA | CTD | PMID:23153324 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC7A6 mRNA | CTD | PMID:28628672 | inulin | multiple interactions | ISO | RGD:1553153 | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A6 mRNA | CTD | PMID:36331819 | L-methionine | multiple interactions | ISO | RGD:1553153 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC7A6 mRNA | CTD | PMID:20938992 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of SLC7A6 mRNA | CTD | PMID:28988120 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of SLC7A6 mRNA | CTD | PMID:26667767 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of SLC7A6 intron | CTD | PMID:30157460 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of SLC7A6 mRNA | CTD | PMID:23649840 | mirex | decreases expression | ISO | RGD:1309193 | 6480464 | Mirex results in decreased expression of SLC7A6 mRNA | CTD | PMID:23153324 | ozone | multiple interactions | ISO | RGD:1553153 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SLC7A6 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC7A6 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | RGD:1553153 | 6480464 | Acetaminophen affects the expression of SLC7A6 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | RGD:1309193 | 6480464 | Acetaminophen results in decreased expression of SLC7A6 mRNA | CTD | PMID:33387578 | PCB138 | increases expression | ISO | RGD:1309193 | 6480464 | 2 more ... | CTD | PMID:23829299 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1553153 | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A6 mRNA | CTD | PMID:36331819 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of SLC7A6 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A6 mRNA | CTD | PMID:27188386 | resveratrol | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of SLC7A6 mRNA | CTD | PMID:26667767 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SLC7A6 mRNA | CTD | PMID:29955902 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of SLC7A6 mRNA | CTD | PMID:25895662 | silver atom | decreases expression | ISO | RGD:1553153 | 6480464 | Silver results in decreased expression of SLC7A6 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | RGD:1553153 | 6480464 | Silver results in decreased expression of SLC7A6 mRNA | CTD | PMID:27131904 | tamoxifen | affects expression | ISO | RGD:1553153 | 6480464 | Tamoxifen affects the expression of SLC7A6 mRNA | CTD | PMID:17555576 | testosterone | multiple interactions | ISO | RGD:1309193 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of SLC7A6 mRNA] | CTD | PMID:20032058 | thioacetamide | increases expression | ISO | RGD:1309193 | 6480464 | Thioacetamide results in increased expression of SLC7A6 mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | RGD:1553153 | 6480464 | titanium dioxide results in decreased expression of SLC7A6 mRNA | CTD | PMID:29264374 | titanium dioxide | multiple interactions | ISO | RGD:1553153 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC7A6 mRNA | CTD | PMID:29950665 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of SLC7A6 mRNA | CTD | PMID:19140230 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of SLC7A6 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SLC7A6 mRNA | CTD | PMID:29154799 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SLC7A6 mRNA | CTD | PMID:23179753, PMID:27188386 | vorinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A6 mRNA | CTD | PMID:27188386 | |